Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
G306 Grass Phase III trial meets primary endpoint
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 3057T' and is clearly identified as a regulatory announcement from the London Stock Exchange's news service (RNS). The content details the interim top-line results of a clinical trial (G306 Phase III trial for Grass MATA MPL) and includes a statement that the announcement 'contains inside information for the purposes of Article 7 of Regulatory (EU) No596/2014'. This is a typical structure for a company issuing a material update via the regulatory news service. Since it is a specific announcement of clinical trial results, it is not a full Annual Report (10-K), Earnings Release (ER), or Interim Report (IR). It is a general regulatory announcement that doesn't fit the other specific categories like Director's Dealing (DIRS) or Dividend Notice (DIV). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such market disclosures.
2023-11-14 English
Director/PCA Dealing
Director's Dealing Classification · 100% confidence The document is a formal notification published via RNS (Regulatory News Service) of the London Stock Exchange. The content explicitly details a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' Specifically, it reports the acquisition of ordinary shares by an entity closely associated with a Non-Executive Director. This type of insider transaction reporting falls directly under the definition of Director's Dealing (DIRS). Although it uses the RNS distribution system, the specific content is about insider trading, making DIRS the most precise classification over the general RNS fallback.
2023-11-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to 'Acquisition or disposal of voting rights', 'Total positions of person(s) subject to the notification obligation', and details about share ownership percentages crossing thresholds (e.g., 65.103%). This structure is characteristic of a regulatory filing notifying a change in significant share ownership. The RNS Number and the reference to the FCA confirm its regulatory nature. This directly matches the definition for Major Shareholding Notification (MRQ).
2023-11-10 English
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and contains information about the allotment and issuance of new ordinary shares following option exercises, along with a confirmation of the total voting rights as required by Rule 2.9 of the City Code on Takeovers and Mergers. This type of mandatory, timely announcement to the market, often related to share capital changes or corporate actions, is characteristic of a general regulatory filing disseminated via the Regulatory News Service (RNS). While it involves share capital changes (SHA), the primary function here is the mandatory disclosure of the total share count post-event, which fits best under the general regulatory announcement category, RNS, especially given the RNS header and footer.
2023-11-09 English
Update on funding
Capital/Financing Update Classification · 99% confidence The document is identified by the header 'RNS Number : 4149S' and concludes with boilerplate text referencing 'RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory news service announcement. The content discusses an 'Update on funding,' mentions extending the cash runway, and notes ongoing discussions with shareholders regarding future funding needs. This type of announcement, which provides material operational/financial updates but is not a full report (like 10-K or IR) or a specific transaction notice (like DIV or SHA), fits best under the general regulatory announcement category. Given the specific definitions, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, time-sensitive regulatory news release that doesn't fit a more specific code like ER, CAP, or LTR, although it touches upon financing (CAP). Since it is explicitly branded as an RNS release and is short, RNS is chosen over CAP.
2023-11-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 8677Q' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership thresholds, which directly corresponds to the definition of Major Shareholding Notification. The content details the percentage of voting rights held by Abbott Laboratories and its controlled entities, crossing a threshold on 16/10/2023. This aligns perfectly with the 'Major Shareholding Notification' category (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2023-10-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.